National Survey on Clinical Pharmacy Services of Second-level Hospitals in China:Part 2. Analysis on the Status Quo of Clinical Pharmaceutical Services
YAO Dong-ning1, HUANG Yuan-kai2, XI Xiao-yu2, WANG Xiu2, WANG Xiao-jing3, WANG Yi-tao1, YAO Wen-bing2*
1. Institute of Chinese Medical Sciences, University of Macau, Macau SAR 999078, China; 2. Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, China; 3. Chinese Pharmaceutical Association, Beijing 100022, China
Abstract��OBJECTIVE To collect relevant data on the development of clinical pharmaceutical services in secondary hospitals in China and analyze the existing problems of clinical pharmaceutical services and provide relevant policy suggestions. METHODS A face-to-face interview survey was conducted to collect data on the secondary hospital clinical pharmacists�� perception of their own work, physicians�� knowledge of clinical pharmacists�� work and patient��s attitude toward clinical pharmacists�� work, et al which was analyzed with descriptive statistics tools. RESULTS Among the clinical pharmacists, physicians, and patients surveyed, 52.8% of clinical pharmacists think that the clinical pharmacists in the hospital work smoothly, but 35.8% of clinical pharmacists think the configuration of clinical pharmacists in the hospital is unreasonable; 42.0% of the doctors had a basic understanding of the work of clinical pharmacists; the attitude of the clinical pharmacists on medication recommendations or dosing regimens was mainly partly adopted (82.5%). Most of the patients did not understand but had heard of clinical pharmacy services (39.7%).CONCLUSION The work and assignment of clinical pharmacists, understandings between clinical pharmacists and physician, patients of secondary hospitals in China require further improvement.
Ҧ����, ��Ԫ��, ϯ����, ����, �����, ��һ��, Ҧ�ı�. �ҹ�����ҽԺ�ٴ�ҩѧ������״�������о�(��):�ٴ�ҩѧ����չ��״����[J]. �й�ҩѧ��־, 2019, 54(2): 150-157.
YAO Dong-ning, HUANG Yuan-kai, XI Xiao-yu, WANG Xiu, WANG Xiao-jing, WANG Yi-tao, YAO Wen-bing. National Survey on Clinical Pharmacy Services of Second-level Hospitals in China:Part 2. Analysis on the Status Quo of Clinical Pharmaceutical Services. Chinese Pharmaceutical Journal, 2019, 54(2): 150-157.
ASHP guidelines on a standardized method for pharmaceutical care.American society of health-system pharmacists[J]. Am J Hosp Pharm,1996, 53(14):1713-1716.
[2]
YEE G C, HAAS C E. Standards of practice for clinical pharmacists: the time has come[J]. Pharmacotherapy, 2015, 34(8):769-770.
[3]
FENG A M. Improve the management of drug distribution in ward and improve the level of pharmaceutical service[J]. Chin J Clin Rat Drug Use(�ٴ�������ҩ��־), 2014, 19(4):79-80.
[4]
XUAN L I, PENG W X, TANG H M, et al. Analysis of service status and strategies of pharmacy in China[J]. China Health Industry(�й�������ҵ), 2017, 14(30):190-191.
[5]
YUAN S W. Analysis of services status of our country��s clinical pharmacy and its countermeasures[J]. Anti-Infect Pharm, 2016,13(3):494-496.
[6]
SUN Y, HUANG C L, ZHANG M H, et al. Restricted factors of hospital clinical pharmaceutical care capability and discussion of improved countermeasures[J]. Pharm Care Res(ҩѧ�������о�),2016,16(5):369-374.
[7]
PAN C Q, LI X Y, WANG L W, et al. Establishment of the clinical pharmacist working model based on the total quality management in hospital[J]. Chin J Hosp Adm(�л�ҽԺ������־), 2016, 32(3):191-194.
[8]
DESEN L I, WANG Y, SHUISHENG W U. Thinking and suggestion on positioning of clinical TCM pharmacists and the cultivation of post service ability[J]. J China Pharm(�й�ҩ��),2017, 28(36):5170-5173.
[9]
LIU D, ZHANG C, GUI L, et al. Survey of current situation of clinical pharmacy in hospitals above class �� in Hubei Province[J]. Chin J Pharmacoepidemiol(ҩ�����в�ѧ��־), 2011,20(4):186-188.
[10]
YANG Z, WANG Z, WEI J I. An investigation into present clinical pharmacy work in 55 hospitals[J]. Pharm Care Res(ҩѧ�������о�), 2002, 2(1):17-19.
[11]
HU M, JIANG X H, WU Y P, et al. Survey on hospital pharmaceutical care in China and the status quo of clinical pharmacy practice (part 2):survey on status quo of clinical pharmacy practice[J]. J China Pharm(�й�ҩ��), 2009, 20(13):1030-1032.
[12]
ZHOU Y, YANG Y, MENG L, et al. Investigation of the development of clinical pharmacy in 28 hospitals of Jiangsu Province[J]. J China Pharm(�й�ҩ��), 2017, 28(24):3341-3346.
[13]
LIANG L, ZHANG J, WANG Y, et al. Investigation on development of clinical pharmaceutical care of medical institutions in Xi��an[J]. Chin J Hosp Pharm(�й�ҽԺҩѧ��־), 2017, 37(17):1747-1752.
[14]
TING X W, WANG B, WANG Y. Investigation of the evaluation of physicians for clinical pharmaceutical care in 5 third grade class a hospitals in Beijing[J]. J China Pharm(�й�ҩ��), 2016, 27(36):5066-5068.
[15]
LIU Z, CHEN K, YAN T, et al. Investigation of clinical pharmacy work conditions of 4 third-level first class hospital in Guangxi Yulin[J]. J China Pharm(�й�ҩ��), 2017, 28(3):308-311.
[16]
HOU S, WANG Z, SHI W, et al. Investigation and study on the competence required of clinical pharmacist in PIVAS of 63 third-grade class a hospitals in China[J]. J China Pharm(�й�ҩ��), 2017, 28(6):725-729.
[17]
AMERICAN COLLEGE OF CLINICAL PHARMACY, HAMMOND R W, SCHWARTZ A H, et al. Collaborative drug therapy management by pharmacists��2003[J]. Pharmacotherapy: J Human Pharm Drug Ther, 2003, 23(9): 1210-1225.
[18]
CHU S, XING X. Reflections on the current development status of China��s clinical pharmacists[J]. Chin Pharm Aff(�й�ҩ��), 2014, 28(11):1261-1264.
[19]
LI X, PENG W X, YE Y Q, et al. A brief discussion on relationship between clinical pharmacists and multi personnel[J]. Eval Anal Drug-Use Hosp China(�й�ҽԺ��ҩ���������), 2016, 16(s1):227-228.
[20]
CUMMING J M. Health services coverage regulation: an evaluation of policy options for New Zealand[D]. Victoria University of Wellington, 2003.
[21]
AYALEW M B, TAYE K, ASFAW D, et al. Patients��/clients�� expectation toward and satisfaction from pharmacy services[J]. J Res Pharm Pract, 2017, 6(1):21-26.
[22]
MARTIN M T, FABER D M. Patient satisfaction with the clinical pharmacist and prescribers during hepatitis C virus management[J]. J Clin Pharm Ther, 2016, 41(6):645-649.
[23]
GALT K. Using patient expectations and satisfaction data to design a new pharmacy service model in a primary care clinic[J]. J Managed Care Pharm Jmcp, 1997, 3(5):531-540.
[24]
LI H W, HUANG Q, LIU Y, et al. Clinical pharmacist pharmacy services for patients with chronic obstructive pulmonary disease cost impact and satisfaction[J]. Anti-Infect Pharm(����Ⱦҩѧ), 2017, 14(7):1323-1324,1340.
[25]
SY L, LI W F, TAN Q Q, et al. Study on the correlation between analgesia effect and satisfaction degree of pain management in perioperative period of pharmacy service[J]. Strait Pharm J(��Ͽҩѧ), 2017, 29(6):69-71.
[26]
XI X Y, YAO D N, HUANG Y K, et al. National survey on clinical pharmacy services of second-level hospitals in China: Part 1. introduction of survey and basic conditions of clinical pharmacy service provision[J]. Chin Pharm J(�й�ҩѧ��־),2018,53(23):2058-2064.
[27]
ZHU J. An overview of the American clinical pharmacist system[J]. Beijing J Trad Chin Med(������ҽҩ), 2008, 27(6):469-470.
[28]
FAN H W, XIANG Q, REN G H, et al. Evaluation and systematic review of working mode of clinical pharmacists in China[J]. Clin Med J(�ٴ�ҩ��������־), 2016, 14(4):23-29.
[29]
XIAO J Y, CUI X L, LIU Y, et al. Responsibility and mission of clinical pharmacists given by new medical reform[J]. Chin J Clin Pharm(�й��ٴ�ҩ��ѧ��־), 2017, 33(11):1042-1044.
[30]
SU L, TANG Y. The basic elements of clinical pharmacists should be defined in the clinical treatment team[J]. J China Pharm(�й�ҩ��), 2010, 21(30):2794-2795.
[31]
XU P. Exploration on the differences of training process for clinical pharmacist and work patterns between China and the United States[J]. Chin Hosp(�й�ҽԺ), 2015, 19(10):48-50.
[32]
XIAO L W, WANG H C. Present situation and countermeasures of clinical pharmacists in dimethyl hospitals[J]. Chin J Hosp Pharm(�й�ҽԺҩѧ��־), 2018, 38(1):100-103.
[33]
KEITHM O, SYLVIA A D, OLIVIA V N, et al. American clinical pharmacy education and practice[J]. J China Pharm(�й�ҩ��), 2016,27(2):145-149.
[34]
YAN Y, ZHANG J Y, LIU J, et al. The enlightenment of the development of the laws and regulations of clinical pharmacists in the United[J]. China Pharm(�й�ҩʦ), 2016,19 (11):2128-2130.
[35]
HALL M N, KRUSE J. Allies in family medicine advocacy: the patient-centered primary care collaborative[J]. Annals Family Med, 2010, 8(1):89.
[36]
ZHU Z, SHANG N. Overview of changes in the practice flow of pharmaceutical care in the United States[J]. China Pharm(�й�ҩʦ), 2015, 18(9):1571-1573.
2019, Vol. 54 
